Manchester Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $825 | Sell |
15
-18
| -55% | -$990 | ﹤0.01% | 1079 |
|
|
2025
Q1 | $2.33K | Sell |
33
-1
| -3% | -$71 | ﹤0.01% | 987 |
|
|
2024
Q4 | $2.24K | Buy |
34
+3
| +10% | +$197 | ﹤0.01% | 977 |
|
|
2024
Q3 | $2.18K | Buy |
31
+10
| +48% | +$703 | ﹤0.01% | 986 |
|
|
2024
Q2 | $1.73K | Buy |
+21
| New | +$1.73K | ﹤0.01% | 964 |
|
|
2024
Q1 | – | Sell |
-6
| Closed | -$579 | – | 1037 |
|
|
2023
Q4 | $579 | Buy |
+6
| New | +$579 | ﹤0.01% | 897 |
|
|
2021
Q1 | – | Sell |
-15
| Closed | -$1K | – | 655 |
|
|
2020
Q4 | $1K | Buy |
15
+12
| +400% | +$800 | ﹤0.01% | 632 |
|
|
2020
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 557 |
|